Sulisobenzone
CAS 4065-45-6
Sulisobenzone (CAS 4065-45-6) is a Phase 2 pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 22165.7875 nM | 8 | - |
| - | AC50 | 840.7666666666668 nM | 3 | - |
| - | IC50 | 19976.309999999998 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BENZOPHENONE-4 | 1311567 | SU | MTHSPL |
| Sulisobenzone | 1311567 | SU | MTHSPL |
| SULISOBENZONE | 1311567 | SU | MTHSPL |
| sulisobenzone | 1311567 | SU | MTHSPL |
| sulisobenzone | 1311567 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sulisobenzone used for in pharmaceutical contexts?
Sulisobenzone (CAS 4065-45-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sulisobenzone?
No adverse-event association or SIDER side-effect rows are rendered for Sulisobenzone in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sulisobenzone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Sulisobenzone (Benzophenone-4) with EU status "permitted".
What clinical phase is Sulisobenzone in?
Sulisobenzone is rendered with ChEMBL max phase 2.